Liver Cell Mitophagy in Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis

Liver Cell Mitophagy in Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately one-third of the global population. MASLD and its advanced-stage liver fibrosis and cirrhosis are the leading causes of liver failure and liver-related death worldwide. Mitochondria are crucial organelles in liver...

Full description

Bibliographic Details
Main Authors: Jiaxin Chen, Linge Jian, Yangkun Guo, Chengwei Tang, Zhiyin Huang, Jinhang Gao
Format: Article
Language:English
Published: MDPI AG 2024-06-01
Series:Antioxidants
Subjects:
metabolic dysfunction-associated steatotic liver disease (MASLD)
metabolic dysfunction-associated steatohepatitis (MASH)
liver fibrosis
mitochondria
mitophagy
hepatocytes
Online Access:https://www.mdpi.com/2076-3921/13/6/729

Internet

https://www.mdpi.com/2076-3921/13/6/729

Similar Items